
Sign up to save your podcasts
Or


Heather Turner, CEO at Carmot Therapeutics, speaks with Venrock partner Nimish Shah to discuss her time as CEO. Turner shares how she guided the company through its acquisition by Roche, advice for other CEOs on the verge of an acquisition, her perspective on the GLP-1 market and what excites her about the future of biotech.
By Venrock, a venture capital firm4.8
6262 ratings
Heather Turner, CEO at Carmot Therapeutics, speaks with Venrock partner Nimish Shah to discuss her time as CEO. Turner shares how she guided the company through its acquisition by Roche, advice for other CEOs on the verge of an acquisition, her perspective on the GLP-1 market and what excites her about the future of biotech.

1,290 Listeners

2,671 Listeners

2,444 Listeners

1,100 Listeners

341 Listeners

324 Listeners

396 Listeners

5,522 Listeners

9,902 Listeners

34 Listeners

506 Listeners

19 Listeners

265 Listeners

521 Listeners

1,356 Listeners